Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study - Wikidata - awgldk - TriplyDB

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

http://www.wikidata.org/entity/Q34532266

about

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis Gastroenterology Drug therapy of ulcerative colitis Ulcerative colitis: current treatment strategies and future prospects.Pros and cons of medical management of ulcerative colitis.Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters.Histological healing after infliximab induction therapy in children with ulcerative colitis Medical treatment of ulcerative colitis Efficacy and safety of drugs for ulcerative colitis.Review article: the histological assessment of disease activity in ulcerative colitis.Prophylactic and therapeutic effects of oral budesonide for acute radiation-induced enteritis and colitis in rats.Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.Histological healing in inflammatory bowel disease: a still unfulfilled promise.Clinical pharmacology and therapeutics.Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters.Sulfasalazine decreases acute gastrointestinal complications due to pelvic radiotherapy.Olsalazine-related diarrhoea: does rat intestine adapt in vivo?A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.Calcium Coordination Solids for pH-Triggered Release of Olsalazine.A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease.

P2860

Q24185876-B3DE6253-6C02-417D-9275-07FCCAD0C696 Q24198024-1F7369C7-3A71-4E57-8A06-1244037E96EC Q24246220-A2D485E3-1D33-4A4B-85D5-0FF913BC7AC7 Q24248026-54EBBADA-205E-4E01-A49A-1B54C504A23F Q27486369-248B3633-2A4B-44AD-B9CA-0F4F4E87F90A Q34403155-A36DCB34-E3AC-4BD3-8513-B114B9ABD912 Q34408967-DE8A1021-A3EB-4956-89FF-1CE02B3FF99C Q35100726-5214C9DC-9F4D-4607-9469-2E47F8284DF7 Q36055120-6AF4F683-C1BA-4A39-83C0-B85B21872FBD Q36105637-8A9C764F-5296-4D44-B224-33064FEEEA0A Q37427481-72D9E309-5EB4-4760-A797-8790E6B41D49 Q37727232-44268706-901E-45FC-871E-59FE1A7AD1D2 Q38573248-1037AF14-4277-4738-83D7-6E550D5E7C4F Q39171685-A29CCB69-C965-4234-B1BF-3981223E0212 Q42682893-E4A9D94C-5D47-455D-B42B-F1D528B9CC22 Q43240077-C29772A1-EDA8-4720-ABB9-80B3510F5654 Q43263960-3D8F6F79-FCAA-4E71-9DD4-F2476BBFF406 Q43514773-C5728649-9F60-4F49-BC19-7A57AE9B8D4B Q43695399-801270B4-3697-42A6-B2B2-D52A0E70B780 Q44063610-81BD616D-D8A3-49D0-B223-4C34E1B16E13 Q45713744-53B3A8D8-1A30-4120-893F-07D8240F0FC5 Q46259583-A6489E1A-E8F1-4133-89DB-27BC4822D083 Q46977299-660F2BC5-CFAE-4BE8-B6B3-BA5ADC96A923

P2860

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

http://www.wikidata.org/entity/Q34532266

description

1989 nî lūn-bûn

@nan

1989 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年学术文章

@wuu

1989年学术文章

@zh-cn

1989年学术文章

@zh-hans

1989年学术文章

@zh-my

1989年学术文章

@zh-sg

1989年學術文章

@yue

name

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@ast

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@en

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@nl

type

label

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@ast

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@en

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@nl

prefLabel

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@ast

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@en

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@nl

P1433

Q34532266-F9B286CC-6F1A-4E1E-810B-FBF8578C90C3

P1476

Q34532266-C20A60B1-C4A5-40A5-A6C3-52146D7458B5

P2093

Q34532266-3EB39F3B-2BBD-4329-A5D9-A83FA74777A7

Q34532266-432AA80D-E31A-4FD6-AFAB-5A44F2609DF3

Q34532266-AB6DA2EC-BF06-4176-9B5F-BBDE54C7408C

Q34532266-DCC11A48-77E6-467A-9C10-C3BC337C52A1

Q34532266-F245EF1C-4891-47EE-828F-F117348E416D

Q34532266-F96059CD-B5EE-48F0-BA06-6FA63EC776C1

P2860

Q34532266-5134A194-D9B8-47C2-9562-CE69A39D8986

Q34532266-6FD8EF1C-85B6-4370-B8BC-5C87A33CBCA8

Q34532266-7B1C73A5-C0EF-4239-90E6-71FBF34B119C

Q34532266-7D41CAB5-E3EB-4C52-AB70-8A14FFF967C9

Q34532266-8C934302-AA21-46EB-9A51-539A0F9DEE69

Q34532266-8F5916A2-779E-4C40-B62A-907CD304F496

Q34532266-A3C56EE8-2CCF-458B-B054-6A8E97B808BC

Q34532266-B293A6DA-0794-4DED-B27B-953168FA0B78

Q34532266-B3601FAE-CB68-4ED0-BC85-7685E23AA6D6

Q34532266-C591834C-6C16-4181-BA16-0A3F54BE86E9

P304

Q34532266-8DD54576-CE20-408E-8520-FD5A2D9E4195

P31

Q34532266-3D57BD1B-7AA7-4824-88A8-9EA8F4F4D3F9

P356

Q34532266-2B6F52E7-5A78-4E55-9201-39C0D72FD387

P407

Q34532266-890D8510-CB80-4C89-940D-02F8081FE33A

P433

Q34532266-1AA47ECE-63D7-4FA9-AB62-44930B781218

P478

Q34532266-7B2ADAD9-0CA6-4D4B-9AE2-150725D2E426

P577

Q34532266-DE7474B2-916A-4EF0-B2A1-838D3EB698C2

P5875

Q34532266-8DA7C937-9BD6-485E-820F-CC3C5FEAA8EB

P698

Q34532266-6A34306F-807B-4B56-B12C-19A522DF8954

P932

Q34532266-88455712-89DA-4E5F-9D21-257BDD9EDFCC

P356

P1433

P1476

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

@en

P2093

Cann PA

http://www.w3.org/2001/XMLSchema#string

Corbett CL

http://www.w3.org/2001/XMLSchema#string

Dundas SA

http://www.w3.org/2001/XMLSchema#string

Holdsworth CD

http://www.w3.org/2001/XMLSchema#string

Palmer KR

http://www.w3.org/2001/XMLSchema#string

Rao SS

http://www.w3.org/2001/XMLSchema#string

P2860

Olsalazine in active ulcerative colitis.

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.

Influence of olsalazine on gastrointestinal transit in ulcerative colitis.

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy.

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

An experiment to determine the active therapeutic moiety of sulphasalazine.

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

P304

675-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.30.5.675

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1989-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20589436

http://www.w3.org/2001/XMLSchema#string

P698

2567266

http://www.w3.org/2001/XMLSchema#string

P932

1434223

http://www.w3.org/2001/XMLSchema#string